“The key finding is the ability of the test to make an early prediction of response and disease control, just three to four weeks after initiation of immunotherapy. The flexibility to switch treatments early on based on an accurate prediction has great potential to improve the treatment of many cancers.”
“The basic idea behind our tests is that since each and every cell in the body has its genomic material half from your father and half from your mother, there should not be significant changes to these genetic blueprints with age. However, if cancer cells are present, they are continuously changing their genetic material and their genomic patterns are markedly different from all the other healthy cells in your body. We can specifically detect this cancerous material or mutations in the plasma.“
Chronix Biomedical presents positive data on prognostic test in head/neck cancer study data at ASCO. Study finds CNI score to be a stronger predictor of time to recurrence in head and neck cancer than current method based on lymph node invasion.